Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$72.62 - $79.98 $31,299 - $34,471
-431 Reduced 4.71%
8,719 $672,000
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $53,917 - $64,652
877 Added 10.6%
9,150 $668,000
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $8,259 - $9,628
-154 Reduced 1.83%
8,273 $516,000
Q3 2021

Oct 22, 2021

BUY
$59.17 - $69.31 $3,491 - $4,089
59 Added 0.71%
8,427 $499,000
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $8,915 - $9,708
-144 Reduced 1.69%
8,368 $559,000
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $36,494 - $41,045
-615 Reduced 6.74%
8,512 $538,000
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $169,755 - $192,364
-2,940 Reduced 24.36%
9,127 $566,000
Q3 2020

Oct 23, 2020

SELL
$57.43 - $63.64 $34,745 - $38,502
-605 Reduced 4.77%
12,067 $728,000
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $18,748 - $21,918
342 Added 2.77%
12,672 $745,000
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $43,894 - $63,788
-946 Reduced 7.13%
12,330 $688,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $186,259 - $242,959
3,785 Added 39.88%
13,276 $852,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $34,985 - $41,480
-818 Reduced 7.93%
9,491 $481,000
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $8,790 - $9,719
-197 Reduced 1.88%
10,309 $468,000
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $45,255 - $53,961
-1,003 Reduced 8.71%
10,506 $501,000
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $24,282 - $31,488
-498 Reduced 4.15%
11,509 $598,000
Q3 2018

Nov 06, 2018

SELL
$55.19 - $62.25 $13,411 - $15,126
-243 Reduced 1.98%
12,007 $745,000
Q2 2018

Aug 07, 2018

SELL
$50.53 - $62.98 $3,284 - $4,093
-65 Reduced 0.53%
12,250 $678,000
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $18,515 - $21,314
-309 Reduced 2.45%
12,315 $779,000
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $140,918 - $153,637
-2,351 Reduced 15.7%
12,624 $774,000
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $827,069 - $954,506
14,975
14,975 $955,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cadence Bank Na Portfolio

Follow Cadence Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank Na with notifications on news.